Park­er In­sti­tute for Can­cer Im­munother­a­py in­vests an­oth­er $125M in­to re­search

The Park­er In­sti­tute for Can­cer Im­munother­a­py, a re­search net­work es­tab­lished by tech en­tre­pre­neur Sean Park­er, an­nounced a new $125 mil­lion in­vest­ment.

The lat­est in­vest­ment comes …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER